Bengtsson Carl Martin
Known title: Chief Financial OfficerCIK: 0001766386
Associated companies
Transaction History
| BCPC | ▼ Sell | Tax Withholding | 302 | $54K | 2/12/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 2,416 | $432K | 2/11/2026 | View on chart |
| BCPC | ▲ Buy | Grant | 4,718 | $0 | 2/11/2026 | View on chart |
| BCPC | ▲ Buy | Grant | 3,610 | $0 | 2/11/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 863 | $149K | 2/8/2026 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 2,781 | $454K | 2/13/2025 | View on chart |
| BCPC | ▲ Buy | Grant | 5,432 | $0 | 2/13/2025 | View on chart |
| BCPC | ▲ Buy | Grant | 2,360 | $0 | 2/12/2025 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 777 | $124K | 2/10/2025 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 832 | $121K | 2/11/2024 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 2,868 | $411K | 2/8/2024 | View on chart |
| BCPC | ▲ Buy | Grant | 4,965 | $0 | 2/8/2024 | View on chart |
| BCPC | ▲ Buy | Grant | 2,100 | $0 | 2/8/2024 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 501 | $68K | 2/13/2023 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 1,759 | $243K | 2/8/2023 | View on chart |
| BCPC | ▲ Buy | Grant | 3,372 | $0 | 2/8/2023 | View on chart |
| BCPC | ▲ Buy | Grant | 1,620 | $0 | 2/8/2023 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 664 | $91K | 2/14/2022 | View on chart |
| BCPC | ▲ Buy | Grant | 1,450 | $0 | 2/10/2022 | View on chart |
| BCPC | ▲ Buy | Grant | 3,660 | $0 | 2/10/2022 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 1,873 | $259K | 2/10/2022 | View on chart |
| BCPC | ▼ Sell | Tax Withholding | 2,074 | $289K | 2/4/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Balchem (BCPC) Seen Trading Below Fair Value
A recent Yahoo analysis notes that BCPC is priced below its estimated fair value. The comment highlights a possible valuation gap while the stock sits near a long‑standing support level. This context may be useful for investors reviewing the company's current price relative to its fundamentals.
Balchem (BCPC) Seen Trading Below Fair Value. A recent Yahoo analysis notes that BCPC is priced below its estimated fair value. The comment highlights a possible valuation gap while the stock sits near a long‑standing support level. This context may be useful for investors reviewing the company's current price relative to its fundamentals.